Skip to main content
. 2013 Nov 22;105(1):126–133. doi: 10.1111/cas.12305

Figure 5.

Figure 5

Cancer-specific survival in patients with MUC6-positive gastric cancer based on α1,4-linked N-acetylglucosamine (αGlcNAc) expression. (a) In MUC6-positive differentiated-type adenocarcinoma, patients with αGlcNAc-negative tumors had a significantly poorer outcome than patients with αGlcNAc-positive tumors (P = 0.048). (b) In MUC6-positive undifferentiated-type adenocarcinoma, there was no significant difference between patient survival rate and the presence or absence of αGlcNAc in tumors (P = 0.549).